PARALLAX HEALTH SCIENCES, INC.: 10-K/A filed 2019-12-13

Name: PARALLAX HEALTH SCIENCES, INC.: 10-K/A filed 2019-12-13
Creator: PARALLAX HEALTH SCIENCES, INC.
License: https://creativecommons.org/licenses/by/4.0/

What PARALLAX HEALTH SCIENCES, INC. reported in its annual report amendment filed 2019-12-13 (fiscal FY 2018): 31 published measures, 63 facts as tagged in accession 0001388410-19-000168.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form: 10-K/A (annual report amendment)
Filed: 2019-12-13
Fiscal period: fiscal FY 2018
Accession: 0001388410-19-000168 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All PARALLAX HEALTH SCIENCES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2018-12-31	1,364,357	USD
At 2017-12-31	1,752,036	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2018-12-31	7,314,811	USD
At 2017-12-31	28,190,825	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2018-12-31	-5,950,454	USD
At 2017-12-31	-26,438,789	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2018-12-31	262	USD
At 2017-12-31	183	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2018-01-01 to 2018-12-31	14,783,811	USD	365
2017-01-01 to 2017-12-31	-13,794,751	USD	365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2018-01-01 to 2018-12-31	-1,291,984	USD	365
2017-01-01 to 2017-12-31	-1,351,195	USD	365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2018-01-01 to 2018-12-31	11,739	USD	365
2017-01-01 to 2017-12-31	94,937	USD	365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2018-01-01 to 2018-12-31	1,332,005	USD	365
2017-01-01 to 2017-12-31	1,392,500	USD	365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2018-12-31	-19,190,922	USD
At 2017-12-31	-33,691,386	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2018-01-01 to 2018-12-31	148,335,736	shares	365
2017-01-01 to 2017-12-31	120,493,618	shares	365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2018-01-01 to 2018-12-31	215,576,153	shares	365
2017-01-01 to 2017-12-31	178,292,040	shares	365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2018-01-01 to 2018-12-31	0	USD	365
2017-01-01 to 2017-12-31	0	USD	365

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2018-01-01 to 2018-12-31	3,513,710	USD	365
2017-01-01 to 2017-12-31	2,601,608	USD	365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2018-01-01 to 2018-12-31	-6,634,663	USD	365
2017-01-01 to 2017-12-31	-4,172,719	USD	365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2018-12-31	262	USD
At 2017-12-31	55,419	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2018-12-31	5,115,692	USD
At 2017-12-31	3,679,621	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2018-12-31	785,060	USD
At 2017-12-31	785,060	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2018-12-31	579,035	USD
At 2017-12-31	709,655	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2018-01-01 to 2018-12-31	-8,600	USD	365
2017-01-01 to 2017-12-31	-47,107	USD	365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2018-12-31	158,113,141	shares
At 2017-12-31	136,754,530	shares

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit
At 2018-12-31	-5,950,454	USD
At 2017-12-31	-26,438,789	USD
At 2016-12-31	-17,573,881	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2018-12-31	579,035	USD
At 2017-12-31	709,655	USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

Period	Value	Unit	Days
At 2018-12-31	0	USD
At 2017-12-31	0	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2018-01-01 to 2018-12-31	15,608,209	USD	365
2017-01-01 to 2017-12-31	-10,641,198	USD	365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2018-01-01 to 2018-12-31	6,626,063	USD	365
2017-01-01 to 2017-12-31	4,125,612	USD	365

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2018-01-01 to 2018-12-31	120,620	USD	365
2017-01-01 to 2017-12-31	83,739	USD	365

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2018-01-01 to 2018-12-31	120,620	USD	365
2017-01-01 to 2017-12-31	83,739	USD	365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2018-01-01 to 2018-12-31	22,242,872	USD	365
2017-01-01 to 2017-12-31	-6,468,479	USD	365

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

Period	Value	Unit	Days
2018-01-01 to 2018-12-31	0	USD	365
2017-01-01 to 2017-12-31	0	USD	365

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2018-01-01 to 2018-12-31	0	USD	365
2017-01-01 to 2017-12-31	0	USD	365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2018-01-01 to 2018-12-31	41,250	USD	365
2017-01-01 to 2017-12-31	199,000	USD	365

Inspect the source

Entity: PARALLAX HEALTH SCIENCES, INC. / CIK 0001388410
Captured: 2026-09-22 19:46 UTC
SEC response SHA-256: 94ef7b5cf30837ee48a9b3f8b759fe12b3da087f5b0a8ff4d38505bc8677ecf0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001388410.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))